Skip to main content
. 2015 Apr 15;30(5):569–575. doi: 10.3346/jkms.2015.30.5.569

Table 1. Baseline clinical characteristics.

Characteristics (Unit) eGFR (mL/min/1.73 m2) P values
Overall (n=66) <30 (n=17) 30-59 (n=26) 60-89 (n=23)
Age (yr) 66.9 ± 15.0 68.4 ± 13.4 72.1 ± 8.7 59.9 ± 19.1 0.014
Male 40 (58.0) 10 (58.8) 17 (65.4) 13 (56.5) 0.806
Resting heart rate (beats/min) 95.0 ± 28.5 91.7 ± 33.3 97.2 ± 25.1 95.0 ± 29.5 0.833
Mean blood pressure (mmHg) 98.9 ± 24.8 103.4 ± 23.3 92.6 ± 22.1 102.8 ± 28.1 0.251
Body mass index (kg/m2) 23.0 ± 3.5 22.1 ± 2.7 23.4 ± 3.7 23.1 ± 4.0 0.491
NYHA functional class ≥ III 48 (72.7) 12 (70.6) 22 (84.6) 14 (60.9) 0.960
Diabetes 28 (42.4) 9 (52.9) 15 (57.7) 4 (17.4) 0.010
Hypertension 38 (57.6) 12 (70.6) 14 (53.8) 12 (52.2) 0.449
Atrial fibrillation 21 (31.8) 7 (41.2) 9 (34.6) 5 (21.7) 0.395
Dyslipidemia 22 (33.3) 9 (52.9) 6 (23.1) 7 (30.4) 0.119
Ischemic etiology 23 (34.8) 9 (52.9) 10 (38.5) 4 (17.4) 0.058
Dilated cardiomyopathy 32 (48.5) 5 (29.4) 14 (53.8) 13 (56.5) 0.185
LV ESD (mm) 51.1 ± 10.1 49.4 ± 7.5 51.4 ± 9.9 52.1 ± 12.2 0.703
LV EDD (mm) 60.5 ± 8.9 60.4 ± 6.7 60.0 ± 9.1 61.3 ± 10.4 0.885
LV EF (%) 27.5 ± 8.8 30.4 ± 8.0 26.1 ± 7.4 27.0 ± 10.5 0.271
Serum creatinine (mg/dL) 1.96 ± 1.45 3.98 ± 1.46 1.58 ± 0.36 0.91 ± 0.18 < 0.001
Serum BUN (mg/dL) 37.7 ± 24.5 65.8 ± 27.0 35.5 ± 14.1 19.4 ± 7.1 < 0.001
Serum sodium (mM/L) 136.5 ± 5.7 137.0 ± 5.6 136.4 ± 5.6 136.2 ± 6.2 0.912
Hemoglobin (g/dL) 12.3 ± 2.7 10.8 ± 2.7 12.3 ± 2.4 13.4 ± 2.5 0.006
Renin-angiotensin antagonist 44 (66.7) 9 (52.9) 20 (76.9) 15 (65.2) 0.260
β blocker 29 (43.9) 11 (64.7) 11 (42.3) 7 (30.4) 0.095
Aldosterone antagonist 9 (13.6) 1 (5.9) 5 (19.2) 3 (13.0) 0.457

Values represent the number (percentages) or mean±standard deviation.eGFR, estimated glomerular filtration rate;NYHA, New York Heart Association; LV ESD/EDD, left ventricular end-systolic/diastolic dimension; EF, Ejection fraction; BUN, Blood urea nitrogen.